magnum4djackpot| Jax-B rose more than 26% in early trading, and its application for listing a self-developed new drug was officially submitted

加科思-B（01167）早盘高开涨幅持续扩大magnum4djackpot，现涨25magnum4djackpot.81%magnum4djackpot，报2magnum4djackpot.34港元，成交额636.23万港元。

加科思药业自主研发的KRAS G12C抑制剂glecirasib（JAB-21822）的新药上市申请（NDA）已正式向国家药监局（NMPA）药品审评中心（CDE）提交，用于治疗二线及以上治疗带有KRAS G12C突变的晚期或转移性非小细胞肺癌患者。

Tags:

Prev: synergylandcrypto| ETF fund flow: On May 6, China SSE 50ETF received a net redemption of 1.161 billion yuan, Jiashi CSI 300ETF received a net redemption of 792 million yuan (attached photo)
Next: rocketbet168slot| Made in China Network's 2024 Super Sea Season "Two-Line Sea" Entering France